FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3043133901> ?p ?o ?g. }

• W3043133901 endingPage "580" @default.
• W3043133901 startingPage "566" @default.
• W3043133901 abstract "Preclinical and clinical studies have suggested a potential benefit from COX-2 inhibition on secondary injury activation after spontaneous intracerebral hemorrhage (ICH). The aim of this study was to investigate the effect of pre-admission NSAID use on functional recovery in spontaneous ICH patients. Consecutive adult ICH patients enrolled in the Intracerebral Hemorrhage Outcomes Project (2009–2018) with available 90-day follow-up data were included. Patients were categorized as NSAID (daily COX inhibitor use ≤ 7 days prior to ICH) and non-NSAID users (no daily COX inhibitor use ≤ 7 days prior to ICH). Primary outcome was the ordinal 90-day modified Rankin Scale (mRS) score. Outcomes were compared between cohorts using multivariable regression and propensity score-matched analyses. A secondary analysis excluding aspirin users was performed. The NSAID and non-NSAID cohorts comprised 228 and 361 patients, respectively. After 1:1 matching, the matched cohorts each comprised 140 patients. The 90-day mRS were comparable between the NSAID and non-NSAID cohorts in both the unmatched (aOR = 0.914 [0.626–1.336], p = 0.644) and matched (aOR = 0.650 [0.392–1.080], p = 0.097) analyses. The likelihood of recurrent ICH at 90 days was also comparable between the NSAID and non-NSAID cohorts in both the unmatched (aOR = 0.845 [0.359–1.992], p = 0.701) and matched analyses (aOR = 0.732 [0.241–2.220], p = 0.581). In the secondary analysis, the non-aspirin NSAID and non-NSAID cohorts comprised 38 and 361 patients, respectively. After 1:1 matching, the matched cohorts each comprised 38 patients. The 90-day mRS were comparable between the non-aspirin NSAID and non-NSAID cohorts in both the unmatched (aOR = 0.615 [0.343–1.101], p = 0.102) and matched (aOR = 0.525 [0.219–1.254], p = 0.147) analyses. The likelihood of recurrent ICH at 90 days was also comparable between the non-aspirin NSAID and non-NSAID cohorts in both the unmatched (aOR = 2.644 [0.258–27.091], p = 0.413) and matched (aOR = 2.586 [0.228–29.309], p = 0.443) analyses. After the exclusion of patients with DNR or withdrawal of care status, NSAID use was associated with lower mRS at 90 days (aOR = 0.379 [0.212–0.679], p = 0.001), lower mRS at hospital discharge (aOR = 0.505 [0.278–0.919], p = 0.025) and lower 90-day mortality rates (aOR = 0.309 [0.108–0.877], p = 0.027). History of nonselective COX inhibition may affect functional outcomes in ICH patients. Pre-admission NSAID use did not appear to worsen the severity of presenting ICH or increase the risk of recurrent ICH. Additional clinical studies may be warranted to investigate the effects of pre-admission NSAID use on ICH outcomes." @default.
• W3043133901 created "2020-07-23" @default.
• W3043133901 creator A5009840604 @default.
• W3043133901 creator A5023093297 @default.
• W3043133901 creator A5031553336 @default.
• W3043133901 creator A5033495424 @default.
• W3043133901 creator A5059303705 @default.
• W3043133901 creator A5089204541 @default.
• W3043133901 date "2020-07-16" @default.
• W3043133901 modified "2023-10-14" @default.
• W3043133901 title "History of Nonsteroidal Anti-inflammatory Drug Use and Functional Outcomes After Spontaneous Intracerebral Hemorrhage" @default.
• W3043133901 cites W1539897695 @default.
• W3043133901 cites W1603121691 @default.
• W3043133901 cites W1867240762 @default.
• W3043133901 cites W1978361806 @default.
• W3043133901 cites W1978653473 @default.
• W3043133901 cites W1983177410 @default.
• W3043133901 cites W1986633554 @default.
• W3043133901 cites W1992257099 @default.
• W3043133901 cites W2031299209 @default.
• W3043133901 cites W2036029912 @default.
• W3043133901 cites W2037535652 @default.
• W3043133901 cites W2053254942 @default.
• W3043133901 cites W2058462157 @default.
• W3043133901 cites W2061415222 @default.
• W3043133901 cites W2067516054 @default.
• W3043133901 cites W2072936443 @default.
• W3043133901 cites W2075300189 @default.
• W3043133901 cites W2086065424 @default.
• W3043133901 cites W2087390633 @default.
• W3043133901 cites W2115218353 @default.
• W3043133901 cites W2123301364 @default.
• W3043133901 cites W2136587148 @default.
• W3043133901 cites W2148135820 @default.
• W3043133901 cites W2161820892 @default.
• W3043133901 cites W2162398860 @default.
• W3043133901 cites W2204564504 @default.
• W3043133901 cites W2359884680 @default.
• W3043133901 cites W2594356997 @default.
• W3043133901 cites W2600581080 @default.
• W3043133901 cites W2622670478 @default.
• W3043133901 cites W2766161359 @default.
• W3043133901 cites W2895327928 @default.
• W3043133901 cites W2911851168 @default.
• W3043133901 cites W4292229870 @default.
• W3043133901 cites W78630724 @default.
• W3043133901 doi "https://doi.org/10.1007/s12028-020-01022-1" @default.
• W3043133901 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32676872" @default.
• W3043133901 hasPublicationYear "2020" @default.
• W3043133901 type Work @default.
• W3043133901 sameAs 3043133901 @default.
• W3043133901 citedByCount "2" @default.
• W3043133901 countsByYear W30431339012021 @default.
• W3043133901 countsByYear W30431339012022 @default.
• W3043133901 crossrefType "journal-article" @default.
• W3043133901 hasAuthorship W3043133901A5009840604 @default.
• W3043133901 hasAuthorship W3043133901A5023093297 @default.
• W3043133901 hasAuthorship W3043133901A5031553336 @default.
• W3043133901 hasAuthorship W3043133901A5033495424 @default.
• W3043133901 hasAuthorship W3043133901A5059303705 @default.
• W3043133901 hasAuthorship W3043133901A5089204541 @default.
• W3043133901 hasBestOaLocation W30431339011 @default.
• W3043133901 hasConcept C118552586 @default.
• W3043133901 hasConcept C126322002 @default.
• W3043133901 hasConcept C16568411 @default.
• W3043133901 hasConcept C17923572 @default.
• W3043133901 hasConcept C2777094939 @default.
• W3043133901 hasConcept C2777628954 @default.
• W3043133901 hasConcept C2777736543 @default.
• W3043133901 hasConcept C2778484676 @default.
• W3043133901 hasConcept C2780931571 @default.
• W3043133901 hasConcept C3020199598 @default.
• W3043133901 hasConcept C50382708 @default.
• W3043133901 hasConcept C541997718 @default.
• W3043133901 hasConcept C71924100 @default.
• W3043133901 hasConcept C77350462 @default.
• W3043133901 hasConcept C90924648 @default.
• W3043133901 hasConceptScore W3043133901C118552586 @default.
• W3043133901 hasConceptScore W3043133901C126322002 @default.
• W3043133901 hasConceptScore W3043133901C16568411 @default.
• W3043133901 hasConceptScore W3043133901C17923572 @default.
• W3043133901 hasConceptScore W3043133901C2777094939 @default.
• W3043133901 hasConceptScore W3043133901C2777628954 @default.
• W3043133901 hasConceptScore W3043133901C2777736543 @default.
• W3043133901 hasConceptScore W3043133901C2778484676 @default.
• W3043133901 hasConceptScore W3043133901C2780931571 @default.
• W3043133901 hasConceptScore W3043133901C3020199598 @default.
• W3043133901 hasConceptScore W3043133901C50382708 @default.
• W3043133901 hasConceptScore W3043133901C541997718 @default.
• W3043133901 hasConceptScore W3043133901C71924100 @default.
• W3043133901 hasConceptScore W3043133901C77350462 @default.
• W3043133901 hasConceptScore W3043133901C90924648 @default.
• W3043133901 hasIssue "2" @default.
• W3043133901 hasLocation W30431339011 @default.
• W3043133901 hasOpenAccess W3043133901 @default.
• W3043133901 hasPrimaryLocation W30431339011 @default.
• W3043133901 hasRelatedWork W1971560625 @default.
• W3043133901 hasRelatedWork W2340604327 @default.

• next